You searched for "innovation"

2740 results found

Leading eyecare charity Orbis celebrates the 20th anniversary of Cybersight

Orbis celebrates the 20th anniversary of its award-winning telemedicine and e-learning platform, Cybersight.

PREVIEW: Join us at the TROPHY Ophthalmic Conference 2025!

The highly anticipated TROPHY Ophthalmic Conference returns this year with an impressive lineup of experts, cutting-edge technological advances, and engaging discussions that promise to strengthen the field of ophthalmology. The TROPHY Ophthalmic Conference is Trent Ophthalmic Society's flagship event, provides...

75th Anniversary year of the first intraocular lens implant

The 29th of November 2024 marks the 75th anniversary of the first intraocular lens implant by our Founder, Sir Harold Ridley FRS. The United Kingdom & Ireland Society of Cataract & Refractive Surgeons (UKISCRS) is marking the event with a...

PD-1 and PD-L1 in exenteration specimens

This is an immunohistochemical study looking at variation in the expression of the programmed death-1 receptor (PD-1) and the programmed cell death ligand-1 (PD-L1), comparing cutaneous malignancies which invaded the orbit with uncomplicated nodular basal cell carcinomas. The authors retrospectively...

How do you solve the problem of trachoma in Ethiopia?

Background Trachoma is one of the oldest diseases known to humankind and the leading infectious cause of blindness worldwide. Spread by the bacterium chlamydia trachomatis, it is transmitted through contact with the eyes, eyelids and nose of those infected. The...

RNIB volunteers “honoured” to meet HM The King and HM The Queen

Two volunteers with sight loss visited Windsor earlier this month to meet Royalty and explain how volunteering can bring communities together. Jonathan Abro and Simon Holt, who both volunteer for RNIB (Royal National Institute of Blind People), were part of...

Oxymetazoline hydrochloride for improved symmetry in Graves’ disease

Oxymetazoline hydrochloride 0.1% ophthalmic solution has Food & Drug Administration (FDA) approval for use in involution ptosis. It is an alpha 1 agonist and partial alpha 2 agonist that stimulates Muller’s muscle to lift the lid. The authors of this...

EEG changes following use of cyclopentolate 1% eye drops

Cycloplegic eye drops may affect the central nervous system. This study reports electroencephalogram (EEG) changes in a cohort of 6–15-year-old children. EEG recordings were taken after placebo and two doses of cyclopentolate 1% in 24 awake children (36 children had...

SightCare Awards 2026 – celebrating excellence in independent optometry

The SightCare Awards 2026 are now open for entries - and this year, they’re bigger, bolder and more prestigious than ever. Set against the stunning backdrop of Edgbaston Stadium, Birmingham, the SightCare Awards return in black-tie style on Sunday 26...

Surgical management options for NLDO

The authors aimed to develop a current collective practice profile for management of nasolacrimal duct obstruction (NLDO). They conducted an online survey of American Association of Pediatric Ophthalmology & Strabismus (AAPOS) members of which 142 completed surveys were collected within...

UKISCRS Cornea & Cataract Day 2027

United Kingdom & Ireland Society of Cataract & Refractive Surgeons' Cornea & Cataract Day 2027

Three years of experience with quantiferon-TB Gold Testing in patients with uveitis

Quantiferon-TB Gold is a new alternative to the tuberculin skin test that utilises synthetic peptides representing M. tuberculosis antigens ESAT-6, CFP-10, TB7.7 and upon incubation with whole blood IFN-γ is released from pre-sensitised T cells and can be measured by...